AbbVie Inc. (ABBV) Net margin 2016–2025
AbbVie Inc. (ABBV) net profit margin by fiscal year — reported net income divided by reported revenue.
6.9%FY2025 · since FY2016: 23.2% → 6.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 6.9% | -0.7 pp |
| FY2024 | 7.6% | -1.4 pp |
| FY2023 | 9.0% | -11.4 pp |
| FY2022 | 20.4% | -0.2 pp |
| FY2021 | 20.5% | +10.5 pp |
| FY2020 | 10.1% | -13.6 pp |
| FY2019 | 23.7% | +6.3 pp |
| FY2018 | 17.4% | -1.5 pp |
| FY2017 | 18.8% | -4.4 pp |
| FY2016 | 23.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →